Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.

Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton.... (2020). Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. https://doi.org/10.1055/s-0040-1713152

@article{paper32473596, title={ Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. }, author={ Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH, Global COVID-19 Thrombosis Collaborative Group. }, journal={ Thromb Haemost }, year={ 2020 }, doi={ 10.1055/s-0040-1713152 }, pmid={ 32473596 } }